disclaimer: Rigel Pharmaceuticals

The contents of this World Wide Web (Internet) site are owned or controlled by Rigel Pharmaceuticals, Inc. All contents of the Internet site are protected by worldwide copyright laws. The trademarks, service marks, trade names, and trade dress on this Internet site are protected both in the United States and internationally. No use of any of these may be made without the prior written authorization of Rigel. Identification should be in the proper format according to local statutes and rules. Individuals may download content for personal use only. No modification or further reproduction of the contents is permitted. The contents may otherwise not be copied or used in any way.

Rigel will use reasonable efforts to keep information in this Internet site current and accurate, but the company makes no representations, warranties, or assurances as to the accuracy, currency, or completeness of the information provided. Rigel shall not be liable for any damages or injury resulting from anyone's ability to access, or inability to access, this Internet site, or from anyone's reliance on any information provided at this Internet site. Any hyperlinks from this site or references to other sites for which Rigel has no control over content shall be the responsibility of the user. Any links to other sites are provided as merely a convenience to the users of this Internet site. Rigel shall not be liable for any damages or injury arising from the content of such sites.

Communications you send to Rigel by electronic mail are treated as confidential, and Rigel will not generally use or publicly disclose the content of any such communications, including any ideas, inventions, concepts, techniques, or know-how disclosed therein, for developing, manufacturing, and/or marketing goods or services. The sender of any communications to this Internet site or otherwise to Rigel shall be responsible for the content and information contained therein, including its truthfulness and accuracy.

This website contains "forward-looking" statements, including statements related to anticipated future clinical trials. Any statements contained in this website that are not statements of historical fact may be deemed to be forward-looking statements. Words such as "intends" and "plans" are intended to identify these forward-looking statements. There are a number of important factors that could cause Rigel's plans to differ materially from those indicated by these forward-looking statements, including risks associated with the timing of clinical trials, as well as other risks, detailed from time to time in Rigel's reports filed with the Securities and Exchange Commission, including its Annual Report on Form 10-K for the year ended December 31, 2006 and its Quarterly Report on the Form 10-Q for the quarter ended June 30, 2007. Rigel does not undertake any obligation to update forward-looking statements.